Patients with systemic lupus erythematosus and their experience with vaccination against COVID-19: a descriptive and explanatory study

Submitted: 19 March 2022
Accepted: 1 August 2022
Published: 13 September 2022
Abstract Views: 1038
PDF: 457
Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.

Authors

Not available

Dimensions

Altmetric

PlumX Metrics

Downloads

Download data is not yet available.

Citations

Ceccarelli F, Covelli V, Olivieri G, et al. Systemic lupus erythematosus before and after COVID-19 lockdown: how the perception of disease changes through the lenses of narrative medicine. Healthc. 2021; 9: 726. DOI: https://doi.org/10.3390/healthcare9060726
Priori R, Pellegrino G, Colafrancesco S, et al. SARS-CoV-2 vaccine hesitancy among patients with rheumatic and musculoskeletal diseases: a message for rheumatologists. Ann Rheum Dis. 2021; 80: 953-4. DOI: https://doi.org/10.1136/annrheumdis-2021-220059
Watson, Clark, & Tellegen, 1988. Italian Version Terracciano, McCrae & Costa, 2003.
Wilson RS, Zwickle A, Walpole H. Developing a broadly applicable measure of risk perception. Risk Anal. 2019; 39: 777-91. DOI: https://doi.org/10.1111/risa.13207

How to Cite

Ceccarelli, F., Covelli, V., Olivieri, G., Natalucci, F., Alessandri, C., & Conti, F. (2022). Patients with systemic lupus erythematosus and their experience with vaccination against COVID-19: a descriptive and explanatory study. Reumatismo, 74(2). https://doi.org/10.4081/reumatismo.2022.1491